ARCHIVES

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

This article is from The Cancer Letter archive.

Vol. 27 No. 17 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

Cancer Rates Keep Falling, NCI’s Progress Report Says.

December 7, 2001

Duke Tells ACS The Check for $437,400 Is In The Mail

December 10, 2010

PSA Level Predicts Survival For Prostate Cancer

October 25, 2002

NCI Told To “Cut Out The Nonsense,” Adequately Fund Programs At Centers Required By Mandates

November 5, 1976

Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue

March 29, 2013

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995